Downes Veterinary Limited 09517798 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is Veterinary surgeons Digita Accounts Production Advanced 6.30.9574.0 true true true 09517798 2024-04-01 2025-03-31 09517798 2025-03-31 09517798 bus:OrdinaryShareClass1 bus:CumulativeShares 2025-03-31 09517798 core:CapitalRedemptionReserve 2025-03-31 09517798 core:RetainedEarningsAccumulatedLosses 2025-03-31 09517798 core:ShareCapital 2025-03-31 09517798 core:CurrentFinancialInstruments 2025-03-31 09517798 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 09517798 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 09517798 core:FurnitureFittingsToolsEquipment 2025-03-31 09517798 core:LandBuildings 2025-03-31 09517798 core:MotorVehicles 2025-03-31 09517798 core:OtherPropertyPlantEquipment 2025-03-31 09517798 bus:SmallEntities 2024-04-01 2025-03-31 09517798 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 09517798 bus:FilletedAccounts 2024-04-01 2025-03-31 09517798 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09517798 bus:RegisteredOffice 2024-04-01 2025-03-31 09517798 bus:Director1 2024-04-01 2025-03-31 09517798 bus:Director3 2024-04-01 2025-03-31 09517798 bus:Director4 2024-04-01 2025-03-31 09517798 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-04-01 2025-03-31 09517798 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09517798 core:Goodwill 2024-04-01 2025-03-31 09517798 core:FurnitureFittings 2024-04-01 2025-03-31 09517798 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 09517798 core:LandBuildings 2024-04-01 2025-03-31 09517798 core:MotorVehicles 2024-04-01 2025-03-31 09517798 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 09517798 core:PlantMachinery 2024-04-01 2025-03-31 09517798 1 2024-04-01 2025-03-31 09517798 countries:AllCountries 2024-04-01 2025-03-31 09517798 2024-03-31 09517798 core:FurnitureFittingsToolsEquipment 2024-03-31 09517798 core:LandBuildings 2024-03-31 09517798 core:MotorVehicles 2024-03-31 09517798 core:OtherPropertyPlantEquipment 2024-03-31 09517798 2023-04-01 2024-03-31 09517798 2024-03-31 09517798 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-03-31 09517798 core:CapitalRedemptionReserve 2024-03-31 09517798 core:RetainedEarningsAccumulatedLosses 2024-03-31 09517798 core:ShareCapital 2024-03-31 09517798 core:CurrentFinancialInstruments 2024-03-31 09517798 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 09517798 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 09517798 core:FurnitureFittingsToolsEquipment 2024-03-31 09517798 core:LandBuildings 2024-03-31 09517798 core:MotorVehicles 2024-03-31 09517798 core:OtherPropertyPlantEquipment 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09517798

Downes Veterinary Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2025

 

Downes Veterinary Limited

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 9

 

Downes Veterinary Limited

Company Information

Directors

Mr Walter John Downes

Mrs Samantha Downes

Mr Tom Downes

Registered office

Unit 17
Glan yr Afon Industrial Estate
Aberystwyth
Ceredigion
SY23 3JQ

Accountants

Sarah Lloyd Chartered Accountants
Brynwerydd
Gwenlli
Synod Inn
Ceredigion
SA44 6JH

 

Downes Veterinary Limited

(Registration number: 09517798)
Abridged Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

5

245,068

180,480

Current assets

 

Stocks

6

85,000

66,527

Debtors

7

91,926

82,859

Cash at bank and in hand

 

161,722

206,704

 

338,648

356,090

Creditors: Amounts falling due within one year

(220,304)

(152,362)

Net current assets

 

118,344

203,728

Total assets less current liabilities

 

363,412

384,208

Creditors: Amounts falling due after more than one year

(15,415)

(25,797)

Accruals and deferred income

 

(3,130)

(3,005)

Net assets

 

344,867

355,406

Capital and reserves

 

Called up share capital

8

8

10

Capital redemption reserve

2

-

Retained earnings

344,857

355,396

Shareholders' funds

 

344,867

355,406

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 December 2025 and signed on its behalf by:
 

 

Downes Veterinary Limited

(Registration number: 09517798)
Abridged Balance Sheet as at 31 March 2025

.........................................
Mr Walter John Downes
Director

.........................................
Mrs Samantha Downes
Director

.........................................
Mr Tom Downes
Director

     
 

Downes Veterinary Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Unit 17
Glan yr Afon Industrial Estate
Aberystwyth
Ceredigion
SY23 3JQ
Wales

These financial statements were authorised for issue by the Board on 30 December 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Downes Veterinary Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% reducing balance

Motor vehicles

20% reducing balance

Furniture and fittings

10% reducing balance

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

20% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

Downes Veterinary Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Downes Veterinary Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 21 (2024 - 21).

4

Intangible assets

Total
£

Cost or valuation

At 1 April 2024

50,620

At 31 March 2025

50,620

Amortisation

At 1 April 2024

50,620

At 31 March 2025

50,620

Carrying amount

At 31 March 2025

-

 

Downes Veterinary Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

5

Tangible assets

Land and buildings
£

Furniture, fittings and equipment
 £

Motor vehicles
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 April 2024

61,207

48,732

23,500

116,794

250,233

Additions

38,626

11,548

-

44,401

94,575

At 31 March 2025

99,833

60,280

23,500

161,195

344,808

Depreciation

At 1 April 2024

-

9,696

8,732

51,325

69,753

Charge for the year

-

5,059

2,954

21,974

29,987

At 31 March 2025

-

14,755

11,686

73,299

99,740

Carrying amount

At 31 March 2025

99,833

45,525

11,814

87,896

245,068

At 31 March 2024

61,207

39,036

14,768

65,469

180,480

Included within the net book value of land and buildings above is £99,833 (2024 - £61,207) in respect of freehold land and buildings.
 

 

Downes Veterinary Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

6

Stocks

2025
£

2024
£

Other inventories

85,000

66,527

7

Debtors

Debtors includes £Nil (2024 - £Nil) due after more than one year.

8

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary shares of £1 each

8

8

10

10

       

Pursuant to section 690 of the Companies Act 2006 and the Company's articles of association, the Company authorised the purchase of two ordinary shares, for a consideration of £145,744, paid fully out of distributable profits.
Pursuant to section 706 of the Companies Act 2006, the Company cancelled the shares on 16th July 2024.
Prior clearance was sought from HMRC and notification received that section 1033 CTA 2010 applies to the company’s purchase of its own shares.

9

Dividends

2025

2024

£

£

Final dividend of £Nil (2024 - £Nil) per ordinary share

-

-

Interim dividend of £12,000.00 (2024 - £Nil) per ordinary share

96,000

-

96,000

-

 

 

10

Parent and ultimate parent undertaking

The ultimate controlling party is The Directors.